Selected research
Industry Research
PECAM-1 Protein Industry Research Report 2026
Market perspective
The global PECAM-1 Protein market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for PECAM-1 Protein is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for PECAM-1 Protein is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for PECAM-1 Protein is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of PECAM-1 Protein include Abbexa, Abnova, ACROBiosystems, BioLegend, Bio-Rad, Bon Opus Biosciences, Creative Biomart, LifeSpan Biosciences and NKMAX, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global PECAM-1 Protein market in terms of revenue (US$ million) and, where applicable, sales volume (Kg), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Kg) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
PECAM-1 Protein Market by Company
Abbexa
Abnova
ACROBiosystems
BioLegend
Bio-Rad
Bon Opus Biosciences
Creative Biomart
LifeSpan Biosciences
NKMAX
OriGene
R&D Systems
Sino Biological
PECAM-1 Protein Segment by Type
Mouse
Rabbit
Others
PECAM-1 Protein Segment by Application
Laboratory
Hospital
Others
PECAM-1 Protein Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global PECAM-1 Protein market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of PECAM-1 Protein and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of PECAM-1 Protein.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of PECAM-1 Protein manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of PECAM-1 Protein by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of PECAM-1 Protein in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Mouse
- Rabbit
- Others
Applications
- Laboratory
- Hospital
- Others
Companies covered
- Abbexa
- Abnova
- ACROBiosystems
- BioLegend
- Bio-Rad
- Bon Opus Biosciences
- Creative Biomart
- LifeSpan Biosciences
- NKMAX
- OriGene
- R&D Systems
- Sino Biological
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global PECAM-1 Protein Market Size (2021-2032)
- 2.2.2 Global PECAM-1 Protein Sales (2021-2032)
- 2.2.3 Global PECAM-1 Protein Market Average Price (2021-2032)
- 2.3 PECAM-1 Protein by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Mouse
- 2.3.3 Rabbit
- 2.3.4 Others
- 2.4 PECAM-1 Protein by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Laboratory
- 2.4.3 Hospital
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global PECAM-1 Protein Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global PECAM-1 Protein Sales (Kg) of Manufacturers (2021-2026)
- 3.3 Global PECAM-1 Protein Revenue of Manufacturers (2021-2026)
- 3.4 Global PECAM-1 Protein Average Price by Manufacturers (2021-2026)
- 3.5 Global PECAM-1 Protein Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of PECAM-1 Protein, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of PECAM-1 Protein, Product Type & Application
- 3.8 Global Manufacturers of PECAM-1 Protein, Established Date
- 3.9 Global PECAM-1 Protein Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Abbexa
- 4.1.1 Abbexa Company Information
- 4.1.2 Abbexa Business Overview
- 4.1.3 Abbexa PECAM-1 Protein Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Abbexa PECAM-1 Protein Product Portfolio
- 4.1.5 Abbexa Recent Developments
- 4.2 Abnova
- 4.2.1 Abnova Company Information
- 4.2.2 Abnova Business Overview
- 4.2.3 Abnova PECAM-1 Protein Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Abnova PECAM-1 Protein Product Portfolio
- 4.2.5 Abnova Recent Developments
- 4.3 ACROBiosystems
- 4.3.1 ACROBiosystems Company Information
- 4.3.2 ACROBiosystems Business Overview
- 4.3.3 ACROBiosystems PECAM-1 Protein Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 ACROBiosystems PECAM-1 Protein Product Portfolio
- 4.3.5 ACROBiosystems Recent Developments
- 4.4 BioLegend
- 4.4.1 BioLegend Company Information
- 4.4.2 BioLegend Business Overview
- 4.4.3 BioLegend PECAM-1 Protein Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 BioLegend PECAM-1 Protein Product Portfolio
- 4.4.5 BioLegend Recent Developments
- 4.5 Bio-Rad
- 4.5.1 Bio-Rad Company Information
- 4.5.2 Bio-Rad Business Overview
- 4.5.3 Bio-Rad PECAM-1 Protein Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Bio-Rad PECAM-1 Protein Product Portfolio
- 4.5.5 Bio-Rad Recent Developments
- 4.6 Bon Opus Biosciences
- 4.6.1 Bon Opus Biosciences Company Information
- 4.6.2 Bon Opus Biosciences Business Overview
- 4.6.3 Bon Opus Biosciences PECAM-1 Protein Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Bon Opus Biosciences PECAM-1 Protein Product Portfolio
- 4.6.5 Bon Opus Biosciences Recent Developments
- 4.7 Creative Biomart
- 4.7.1 Creative Biomart Company Information
- 4.7.2 Creative Biomart Business Overview
- 4.7.3 Creative Biomart PECAM-1 Protein Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Creative Biomart PECAM-1 Protein Product Portfolio
- 4.7.5 Creative Biomart Recent Developments
- 4.8 LifeSpan Biosciences
- 4.8.1 LifeSpan Biosciences Company Information
- 4.8.2 LifeSpan Biosciences Business Overview
- 4.8.3 LifeSpan Biosciences PECAM-1 Protein Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 LifeSpan Biosciences PECAM-1 Protein Product Portfolio
- 4.8.5 LifeSpan Biosciences Recent Developments
- 4.9 NKMAX
- 4.9.1 NKMAX Company Information
- 4.9.2 NKMAX Business Overview
- 4.9.3 NKMAX PECAM-1 Protein Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 NKMAX PECAM-1 Protein Product Portfolio
- 4.9.5 NKMAX Recent Developments
- 4.10 OriGene
- 4.10.1 OriGene Company Information
- 4.10.2 OriGene Business Overview
- 4.10.3 OriGene PECAM-1 Protein Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 OriGene PECAM-1 Protein Product Portfolio
- 4.10.5 OriGene Recent Developments
- 4.11 R&D Systems
- 4.11.1 R&D Systems Company Information
- 4.11.2 R&D Systems Business Overview
- 4.11.3 R&D Systems PECAM-1 Protein Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 R&D Systems PECAM-1 Protein Product Portfolio
- 4.11.5 R&D Systems Recent Developments
- 4.12 Sino Biological
- 4.12.1 Sino Biological Company Information
- 4.12.2 Sino Biological Business Overview
- 4.12.3 Sino Biological PECAM-1 Protein Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Sino Biological PECAM-1 Protein Product Portfolio
- 4.12.5 Sino Biological Recent Developments
5 Global PECAM-1 Protein Market Scenario by Region
- 5.1 Global PECAM-1 Protein Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global PECAM-1 Protein Sales by Region: 2021-2032
- 5.2.1 Global PECAM-1 Protein Sales by Region: 2021-2026
- 5.2.2 Global PECAM-1 Protein Sales by Region: 2027-2032
- 5.3 Global PECAM-1 Protein Revenue by Region: 2021-2032
- 5.3.1 Global PECAM-1 Protein Revenue by Region: 2021-2026
- 5.3.2 Global PECAM-1 Protein Revenue by Region: 2027-2032
- 5.4 North America PECAM-1 Protein Market Facts & Figures by Country
- 5.4.1 North America PECAM-1 Protein Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America PECAM-1 Protein Sales by Country (2021-2032)
- 5.4.3 North America PECAM-1 Protein Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe PECAM-1 Protein Market Facts & Figures by Country
- 5.5.1 Europe PECAM-1 Protein Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe PECAM-1 Protein Sales by Country (2021-2032)
- 5.5.3 Europe PECAM-1 Protein Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific PECAM-1 Protein Market Facts & Figures by Country
- 5.6.1 Asia Pacific PECAM-1 Protein Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific PECAM-1 Protein Sales by Country (2021-2032)
- 5.6.3 Asia Pacific PECAM-1 Protein Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America PECAM-1 Protein Market Facts & Figures by Country
- 5.7.1 South America PECAM-1 Protein Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America PECAM-1 Protein Sales by Country (2021-2032)
- 5.7.3 South America PECAM-1 Protein Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa PECAM-1 Protein Market Facts & Figures by Country
- 5.8.1 Middle East and Africa PECAM-1 Protein Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa PECAM-1 Protein Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa PECAM-1 Protein Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global PECAM-1 Protein Sales by Type (2021-2032)
- 6.1.1 Global PECAM-1 Protein Sales by Type (2021-2032) & (Kg)
- 6.1.2 Global PECAM-1 Protein Sales Market Share by Type (2021-2032)
- 6.2 Global PECAM-1 Protein Revenue by Type (2021-2032)
- 6.2.1 Global PECAM-1 Protein Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global PECAM-1 Protein Revenue Market Share by Type (2021-2032)
- 6.3 Global PECAM-1 Protein Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global PECAM-1 Protein Sales by Application (2021-2032)
- 7.1.1 Global PECAM-1 Protein Sales by Application (2021-2032) & (Kg)
- 7.1.2 Global PECAM-1 Protein Sales Market Share by Application (2021-2032)
- 7.2 Global PECAM-1 Protein Revenue by Application (2021-2032)
- 7.2.1 Global PECAM-1 Protein Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global PECAM-1 Protein Revenue Market Share by Application (2021-2032)
- 7.3 Global PECAM-1 Protein Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 PECAM-1 Protein Value Chain Analysis
- 8.1.1 PECAM-1 Protein Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 PECAM-1 Protein Production Mode & Process
- 8.2 PECAM-1 Protein Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 PECAM-1 Protein Distributors
- 8.2.3 PECAM-1 Protein Customers
9 Global PECAM-1 Protein Analyzing Market Dynamics
- 9.1 PECAM-1 Protein Industry Trends
- 9.2 PECAM-1 Protein Industry Drivers
- 9.3 PECAM-1 Protein Industry Opportunities and Challenges
- 9.4 PECAM-1 Protein Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst